Young members of the Abu Dhabi ruling family have joined the Sinopharm vaccine study on children.
Sheikh Theyab bin Mohamed bin Zayed Al Nahyan, Chairman of the Abu Dhabi Crown Prince's Court, accompanied his children, nieces and nephews as they participated in the trial.
A video shared by the Abu Dhabi Government Media Office shows the young royals join other children in the study.
In total, 900 volunteers aged 3 to 17 will take part in the 'immune bridge study' with the consent of their parents.
It is seen as a significant next step in combating the pandemic.
ذياب بن محمد بن زايد وأبنائه وأبناء أخوته ينضمون إلى أولياء أمور وأبنائهم في أبوظبي للتطوع في الدراسة التكميلية للاستجابة المناعية للقاح سينوفارم للأطفال الذين تتراوح أعمارهم بين 3 سنوات و17 سنة. pic.twitter.com/RVkJzovS9B
— مكتب أبوظبي الإعلامي (@ADMediaOffice) June 16, 2021
Theyab bin Mohamed bin Zayed accompanies his children, nieces and nephews, who join other families in Abu Dhabi as they participate in the Sinopharm immune bridge study for children aged 3 to 17.
— مكتب أبوظبي الإعلامي (@ADMediaOffice) June 16, 2021
Under the supervision of MoHAP and approved by @DoHSocial, the study is a significant next step in combating the pandemic. It is monitoring the immune response to the vaccine in 900 children, with full parental consent, in preparation to vaccinate children in the near future.
— مكتب أبوظبي الإعلامي (@ADMediaOffice) June 16, 2021
Dubai confirms air interceptions in Marina, Al Sufouh
UAE arrests another 25 for posting misleading content online
One injured as authorities contain fire at Fujairah Oil Industry Zone
Sharjah contains fire at commercial facility in Al Sajaa Industrial Area
Fire contained at Ruwais Industrial Complex after drone strike on Tuesday
Abu Dhabi contains fire at construction site in Al Mushrif
UAE secures return of 6000 nationals amidst regional developments
കുർദിസ്ഥാനിൽ കോൺസുലേറ്റിനു നേരെയുണ്ടായ ഡ്രോൺ ആക്രമണത്തിൽ ശക്തമായി അപലപിച്ച് യുഎഇ
